Further studies on the relationship between USP9X expression of 86 paraffin specimens and different clinical features of enrolled patients with laryngeal cancer showed that the increased expression of USP9X was not significantly associated with sex, age, clinical stage, or lymph node metastasis (p > 0.05). This evidence concerns the gene USP9X and laryngeal carcinoma.